Thursday, September 21, 2017 9:13:44 AM
Austrianova greatly improved CiaB in 2015 and new patent applications were filed.
Method of Freeze Drying Encapsulated Cells
Status: 4/17/2017 Examination is in progress
https://register.epo.org/application?number=EP14744005
Protection of Microbial Cells from Acid Degradation
Status: 6/1/2017 Examination is in progress
https://register.epo.org/application?number=EP12704722
Use of a Polyanionic Composition
Status: 2/10/2017 Request for examination was made
https://register.epo.org/application?number=EP15789170
Great breakdown of this key patent application:
http://www.freshpatents.com/-dt20170622ptan20170173158.php
IMPORTANTLY, Austrianova changed IP law firms to Banner & Witcoff, which is a tier 1 ranked IP and Patent Law firm: https://bannerwitcoff.com/
Method of Freeze Drying Encapsulated Cells
Status: 4/17/2017 Examination is in progress
https://register.epo.org/application?number=EP14744005
Protection of Microbial Cells from Acid Degradation
Status: 6/1/2017 Examination is in progress
https://register.epo.org/application?number=EP12704722
Use of a Polyanionic Composition
Status: 2/10/2017 Request for examination was made
https://register.epo.org/application?number=EP15789170
Great breakdown of this key patent application:
http://www.freshpatents.com/-dt20170622ptan20170173158.php
IMPORTANTLY, Austrianova changed IP law firms to Banner & Witcoff, which is a tier 1 ranked IP and Patent Law firm: https://bannerwitcoff.com/
Know What You Own. My posts should not be construed as investment advice.
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
